ORIONS Money Stocks

[AugustaFriends]

Augusta's Watch Stocks 22-26 April 2013

Other lists (link back for previous post)

Gold has been been down - I am accumulating Gold and Silver

AAU EGO NG

CPRX $.88 -- Alerted at .50 cents on Thursday - I sold at .84 cents AVG --

Will buy back in if it breaks out on Monday





HZNP $ 2.44



LPR $ .98 watch for double Bottom
Lone Pine Resources Inc. (LPR): Engages in the exploration, development, and production of oil and gas properties in Alberta, British Columbia, Quebec, and the Northwest Territories of Canada. Market cap at $102.44M, most recent closing price at $.99. Of the 5 analysts that have set a target price on the stock, the lowest price target stands at $1.46. This implies a potential upside of 47% from current levels.



OCLR $1.20
Oclaro Launches the Industry's First Commercially-Available Dual-Chip Uncooled Pump Lasers for ROADMs
Pump Lasers Reduce Footprint by 2X while Delivering 60% Lower Power Consumption



ONTY $ 2.41
Oncothyreon (ONTY) is a clinical-stage biopharmaceutical company. It develops and markets synthetic vaccines and small molecules that treat the lives and outcomes of cancer patients. This stock is trading up 5% to $2.41 in recent trading.

Three-Month Average Volume: 699,088
From a technical perspective, ONTY is bouncing higher here right above its 50-day moving average of $2.08 with lighter-than-average volume. This move has started to push shares of ONTY into breakout territory, since the stock has taken out some near-term overhead resistance levels at $2.20 to $2.26. At last check, ONY has hit an intraday high of $2.28, and volume is well below its three-month average action of 699,088 shares. This move is quickly pushing ONTY within range of triggering a major breakout trade. That trade will hit if ONTY manages to take out some near-term overhead resistance levels at $2.34 to $2.42 with high volume.
Traders should now look for long-biased trades in ONTY as long as it’s trending above today’s low of $2.14 or above $2.26, and then once it sustains a move or close above those breakout levels with volume that hits near or above 699,088 shares. If that breakout triggers soon, then ONTY will set up to re-fill some of its previous gap down zone from last December that started near $5.



PACB $ 2.18
Pacific Biosciences of California, Inc. (Nasdaq:PACB) will hold its quarterly conference call to discuss First Quarter 2013 financial results on Tuesday, April 23, at 4:30pm Eastern Time.


NOR $3.35

Noranda Aluminum (NYSE: NOR ) has been another player that investors have been closely watching. It's well positioned to benefit from a rebound in aluminum pricing. An improvement in the earnings due to higher aluminum prices will be magnified given that the company is vertically integrated and believes in soups-to- nuts methodology. However, the Street views relatively lower earnings growth for Noranda as compared to peers.

It's interesting to note that the Street was too optimistic on reductions in raw material costs and overestimated the pace of margin recovery. However, Noranda's power rates at a New Madrid, Mo. smelter have increased by 6.6% to date, 2% more than what the market had expected.

Moreover, the company is expected to face challenges in its upstream segments, particularly bauxite and alumina, given the significant leverage to London Metal Exchange (LME) prices.

Bull’s case:

A price target of $10 assumes a 7.1x multiple applied to a projected 2013 EBITDA of $176 million. This EBITDA value results from assuming a 2013 aluminum price of $1.05/lb vs. the base case of $0.95/lb.





NAK $ 2.40
shares of Northern Dynasty Minerals Ltd. (NAK) entered into oversold territory, changing hands as low as $2.40 per share. We define oversold territory using the Relative Strength Index, or RSI, which is a technical analysis indicator used to measure momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30.


NG $ 2.37
NOVAGOLD RESOURCES INC. ( NG ), which fell nearly 8% and hit new year lows Wednesday as bullion prices slumped, has hit fresh year lows today after it announced results for its first quarter ended February 28, 2013 and gave an update on the permitting process for its flagship Donlin Gold project in Alaska. It said: "With approximately US$300 million in cash and cash equivalents at the end of the first quarter, NOVAGOLD has a strong balance sheet and more than sufficient cash to fulfill all of its current financial obligations as well as fund the advancement of the Donlin Gold project through the permitting process and support ongoing activitinoves at its Galore Creek project in British Columbia."


Read more: http://www.nasdaq.com/article/update-novagold-hits-fresh-year-lows-as-announces-q1-2013-results-provides-donlin-gold-update-cm235897#ixzz2R2zrqKC8


BPAX $ 1.15


CORT $1.91
Corcept Therapeutics(CORT), which is engaged in the discovery and development of drugs for the treatment of severe metabolic and psychiatric disorders. This stock has been hammered by the bears during the last six months, with shares off a large 46%.
If you take a look at the chart for Corcept Therapeutics, you'll notice that this stock has been uptrending strong for the last three months, with shares soaring from its low of $1.27 to its recent high of $2.20 a share. During that uptrend, shares of CORT have been mostly making higher lows and higher highs, which is bullish technical price action. That move has now pushed CORT within range of triggering a near-term breakout trade.
Market players should now look for long-biased trades in CORT if it manages to break out above some near-term overhead resistance at $2.20 a share with high volume. Look for a sustained move or close above $2.20 a share with volume that registers near or above its three-month average action of 622,545 shares. If that breakout hits soon, then CORT will set up to re-test or possibly take out its next major overhead resistance levels at $2.50 to $2.75 a share. Any move above $2.75 will then put $2.89 to $3.03 into range for shares of CORT.



CECO $ 2.17